English  |  正體中文  |  简体中文  |  Total items :2823024  
Visitors :  30228289    Online Users :  882
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"morabito a"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 1-9 of 9  (1 Page(s) Totally)
1 
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-04-23T05:56:26Z Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer: Final analysis of the GioTag study Hochmair M.J.;Morabito A.;Hao D.;Yang C.-T.;Soo R.A.;Chih-Hsin Yang;Gucalp R.;Halmos B.;M?Rten A.;Cufer T.; Hochmair M.J.; Morabito A.; Hao D.; Yang C.-T.; Soo R.A.; CHIH-HSIN YANG; Gucalp R.; Halmos B.; M?rten A.; Cufer T.
臺大學術典藏 2020-05-26T09:26:31Z CNS response to osimertinib in patients with T790M-positive advanced NSCLC: Pooled data from two phase II trials Jänne P.A; CHIH-HSIN YANG; Mitsudomi T; Johnson M; Cantarini M; Chih-Hsin Yang;J?nne P.A;Mitsudomi T;Johnson M;Cantarini M;Hodge R;Morabito A;Felip E;De Marinis F;Crin? L;Bazhenova L;Ahn M.-J;Shepherd F.A;Tsai C.-M;Goss G; Goss G; Tsai C.-M; Shepherd F.A; Ahn M.-J; Bazhenova L; Crinò L; de Marinis F; Felip E; Morabito A; Hodge R
臺大學術典藏 2020-05-26T09:26:31Z CNS response to osimertinib in patients with T790M-positive advanced NSCLC: Pooled data from two phase II trials Jänne P.A; CHIH-HSIN YANG; Mitsudomi T; Johnson M; Cantarini M; Chih-Hsin Yang;J?nne P.A;Mitsudomi T;Johnson M;Cantarini M;Hodge R;Morabito A;Felip E;De Marinis F;Crin? L;Bazhenova L;Ahn M.-J;Shepherd F.A;Tsai C.-M;Goss G; Goss G; Tsai C.-M; Shepherd F.A; Ahn M.-J; Bazhenova L; Crinò L; de Marinis F; Felip E; Morabito A; Hodge R
臺大學術典藏 2020-05-26T09:26:25Z Sequential treatment with afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer: An observational study Märten A; Cufer T.; Cufer T.;M?rten A;Golembesky A;Wang L;Halmos B;Gucalp R;Chih-Hsin Yang;Soo R.A;Yang C.-T;Hao D;Morabito A;Hochmair M.J; Hochmair M.J; Morabito A; Hao D; Yang C.-T; Soo R.A; CHIH-HSIN YANG; Gucalp R; Halmos B; Wang L; Golembesky A
臺大學術典藏 2020-05-26T09:26:25Z Sequential treatment with afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer: An observational study Märten A; Cufer T.; Cufer T.;M?rten A;Golembesky A;Wang L;Halmos B;Gucalp R;Chih-Hsin Yang;Soo R.A;Yang C.-T;Hao D;Morabito A;Hochmair M.J; Hochmair M.J; Morabito A; Hao D; Yang C.-T; Soo R.A; CHIH-HSIN YANG; Gucalp R; Halmos B; Wang L; Golembesky A
臺大學術典藏 2020-05-26T09:26:24Z Brigatinib versus crizotinib in ALK-positive non-small-cell lung cancer Popat S.;Kerstein D;Haney J;Gupta N;Tiseo M;Gettinger S.N;Spira A;Ghosh S;Califano R;Felip E;Morabito A;Griesinger F;Bearz A;Kim D.-W;Garcia Campelo R;Delmonte A;Gridelli C;Lee K.H;Chang G.-C;Li J.Y.-C;Hochmair M.J;Lee J.-S;Han J.-Y;Chih-Hsin Yang;Ahn M.-J;Kim H.R;Camidge D.R; Camidge D.R; Kim H.R; Ahn M.-J; CHIH-HSIN YANG; Han J.-Y; Lee J.-S; Hochmair M.J; Li J.Y.-C; Chang G.-C; Lee K.H; Gridelli C; Delmonte A; Garcia Campelo R; Kim D.-W; Bearz A; Griesinger F; Morabito A; Felip E; Califano R; Ghosh S; Spira A; Gettinger S.N; Tiseo M; Gupta N; Haney J; Kerstein D; Popat S.
臺大學術典藏 2020-05-26T09:26:24Z Brigatinib versus crizotinib in ALK-positive non-small-cell lung cancer Popat S.;Kerstein D;Haney J;Gupta N;Tiseo M;Gettinger S.N;Spira A;Ghosh S;Califano R;Felip E;Morabito A;Griesinger F;Bearz A;Kim D.-W;Garcia Campelo R;Delmonte A;Gridelli C;Lee K.H;Chang G.-C;Li J.Y.-C;Hochmair M.J;Lee J.-S;Han J.-Y;Chih-Hsin Yang;Ahn M.-J;Kim H.R;Camidge D.R; Camidge D.R; Kim H.R; Ahn M.-J; CHIH-HSIN YANG; Han J.-Y; Lee J.-S; Hochmair M.J; Li J.Y.-C; Chang G.-C; Lee K.H; Gridelli C; Delmonte A; Garcia Campelo R; Kim D.-W; Bearz A; Griesinger F; Morabito A; Felip E; Califano R; Ghosh S; Spira A; Gettinger S.N; Tiseo M; Gupta N; Haney J; Kerstein D; Popat S.
臺大學術典藏 2020-05-26T09:26:23Z Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer: Updated analysis of the observational GioTag study Cufer T.; Märten A; Wang L; Halmos B; Gucalp R; CHIH-HSIN YANG; Soo R.A; Yang C.-T; Hao D; Hochmair M.J;Morabito A;Hao D;Yang C.-T;Soo R.A;Chih-Hsin Yang;Gucalp R;Halmos B;Wang L;M?rten A;Cufer T.; Hochmair M.J; Morabito A
臺大學術典藏 2020-05-26T09:26:23Z Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer: Updated analysis of the observational GioTag study Cufer T.; Märten A; Wang L; Halmos B; Gucalp R; CHIH-HSIN YANG; Soo R.A; Yang C.-T; Hao D; Hochmair M.J;Morabito A;Hao D;Yang C.-T;Soo R.A;Chih-Hsin Yang;Gucalp R;Halmos B;Wang L;M?rten A;Cufer T.; Hochmair M.J; Morabito A

Showing items 1-9 of 9  (1 Page(s) Totally)
1 
View [10|25|50] records per page